GlassScriptPhysician profile
Audrey R Meyer
NPI 1548318983
$1,398.70
in general payments reported to CMS, 2019-2025
20 companies · $486 in 2025
The $486 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $111 · 2022: $383 · 2023: $163 · 2024: $256 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $904.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $410.26 | 2021-2024 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $346.26 | 2021-2024 | |
| Medtronic, INC. | $142.30 | 2025 | Linq II |
| Averitas Pharma INC. | $70.33 | 2025 | Qutenza |
| Merz Pharmaceuticals, LLC | $57.66 | 2025 | Xeomin, Inbrija |
| Sk Life Science, INC. | $44.87 | 2025 | |
| Tanabe Pharma America, INC. | $43.49 | 2025 | Radicava |
| Ucb, INC. | $43.49 | 2025 | Zilbrysq, Rystiggo |
| Lilly USA, LLC | $30.53 | 2022-2024 | Jardiance |
| Neurocrine Biosciences, INC. | $28.09 | 2025 | |
| Amgen INC. | $23.39 | 2022 | |
| Abbott Laboratories | $22.05 | 2022 | |
| Argenx US, INC. | $21.36 | 2025 | Vyvgart Hytrulo |
| Alexion Pharmaceuticals, INC. | $19.00 | 2025 | Ultomiris |
| Pfizer INC. | $17.08 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $16.89 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.10 | 2024 | Trulance |
| Exact Sciences Corporation | $15.60 | 2023 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $15.14 | 2025 | Hyqvia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audrey Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.